The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20070763
Giuducci et al.

Figure S1 P13K inhibition inhibits CpG-A–mediated IFN-α response in human pDCs.

Figure S2 PI3K does not affect the pDC survival in response to TLR9 stimulation.

Figure S3 PI3K inhibition affects type I IFN–inducible gene expression in CpG-activated pDCs.

Figure S4 PI3K does not affect the maturation of pPDCs in response to TLR7 and 9.

Figure S5 PI3K inhibition does not affect internalization or endosomal localization of CpG ISS in human pDCs.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS